Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
Authors
Keywords
-
Journal
MOLECULAR NEUROBIOLOGY
Volume 57, Issue 11, Pages 4878-4890
Publisher
Springer Science and Business Media LLC
Online
2020-08-19
DOI
10.1007/s12035-020-02054-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
- (2020) Rachel Kelly et al. MOLECULES
- Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology
- (2020) Mikiei Tanaka et al. Frontiers in Neurology
- Transcriptomic Analyses for Identification and Prioritization of Genes Associated With Alzheimer’s Disease in Humans
- (2020) Yuchen Shi et al. Frontiers in Bioengineering and Biotechnology
- Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer’s Disease
- (2019) Lutz Frölich et al. JOURNAL OF ALZHEIMERS DISEASE
- Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
- (2019) Eva Martínez-Pinilla et al. MOLECULAR NEUROBIOLOGY
- Target Enzyme in Alzheimer’s Disease:Acetylcholinesterase Inhibitors
- (2019) Mridula Saxena et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of a novel metal chelator as multifunctional agents for the treatment of Alzheimer’s disease
- (2019) Yingying Wang et al. BIOORGANIC CHEMISTRY
- Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease
- (2019) Tomris Ozben et al. CLINICAL BIOCHEMISTRY
- Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain
- (2019) Jakub Mlost et al. PHARMACOLOGICAL RESEARCH
- ABHD6: Its Place in Endocannabinoid Signaling and Beyond
- (2019) Jessica K. Cao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis
- (2019) B. Teter et al. NEUROBIOLOGY OF DISEASE
- Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
- (2018) Shana M. Augustin et al. ACS Chemical Neuroscience
- Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats
- (2018) Jennifer A. Shearer et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders
- (2018) Laura Kay et al. MOLECULAR NEUROBIOLOGY
- Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease
- (2018) Mélanie Bourque et al. NEUROPHARMACOLOGY
- An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
- (2018) Stephen D. Skaper et al. Frontiers in Cellular Neuroscience
- Application of Metabolomics in Alzheimer’s Disease
- (2018) Jordan Maximillian Wilkins et al. Frontiers in Neurology
- Genetic polymorphisms of the endocannabinoid system in obesity and diabetes
- (2018) Joseph M. Doris et al. DIABETES OBESITY & METABOLISM
- Microglia in neurodegeneration
- (2018) Suzanne Hickman et al. NATURE NEUROSCIENCE
- TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
- (2018) Honghua Zheng et al. Frontiers in Aging Neuroscience
- TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
- (2017) Honghua Zheng et al. JOURNAL OF NEUROSCIENCE
- Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
- (2017) Anastasia G. Efthymiou et al. Molecular Neurodegeneration
- Microglia emerge as central players in brain disease
- (2017) Michael W Salter et al. NATURE MEDICINE
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- (2017) Tommaso Cassano et al. Frontiers in Neuroscience
- In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
- (2017) Georgia Watt et al. Frontiers in Pharmacology
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
- (2016) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis
- (2016) Lauren Hirsch et al. NEUROEPIDEMIOLOGY
- TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
- (2016) Felix L. Yeh et al. NEURON
- Cannabis sativa: The Plant of the Thousand and One Molecules
- (2016) Christelle M. Andre et al. Frontiers in Plant Science
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
- (2015) Yaming Wang et al. CELL
- Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
- (2015) Ross B. Mounsey et al. EXPERIMENTAL NEUROLOGY
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Neuroprotective Potential of Adenosine A2Aand Cannabinoid CB1Receptor Antagonists in an Animal Model of Parkinson Disease
- (2014) Silvia Cerri et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
- (2014) Jason D Ulrich et al. Molecular Neurodegeneration
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
- (2013) David Olivares et al. Current Alzheimer Research
- Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia
- (2011) Anand Gururajan et al. BEHAVIOURAL BRAIN RESEARCH
- Glia: Initiators and progressors of pathology in Parkinson's disease
- (2011) Glenda M. Halliday et al. MOVEMENT DISORDERS
- Alzheimer's Disease
- (2011) D. J. Selkoe Cold Spring Harbor Perspectives in Biology
- Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation
- (2009) Javorina Milosevic et al. Molecular Neurodegeneration
- Mutation Analysis of the PINK1 Gene in 391 Patients With Parkinson Disease
- (2008) Ryuya Kumazawa et al. ARCHIVES OF NEUROLOGY
- Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System
- (2008) Kay Ahn et al. CHEMICAL REVIEWS
- Pathophysiology of Parkinsonism
- (2008) Adriana Galvan et al. CLINICAL NEUROPHYSIOLOGY
- Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid–linked events in Down’s syndrome
- (2008) E. Núñez et al. NEUROSCIENCE
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Marijuana Neurobiology and Treatment
- (2008) Ahmed Elkashef et al. Substance Abuse
- Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
- (2007) G Esposito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats
- (2007) Yannick Marchalant et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation